JP2017061471A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017061471A5 JP2017061471A5 JP2016204089A JP2016204089A JP2017061471A5 JP 2017061471 A5 JP2017061471 A5 JP 2017061471A5 JP 2016204089 A JP2016204089 A JP 2016204089A JP 2016204089 A JP2016204089 A JP 2016204089A JP 2017061471 A5 JP2017061471 A5 JP 2017061471A5
- Authority
- JP
- Japan
- Prior art keywords
- multimer
- component
- protein
- cell
- components
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161484052P | 2011-05-09 | 2011-05-09 | |
| US61/484,052 | 2011-05-09 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014510413A Division JP2014517690A (ja) | 2011-05-09 | 2012-05-08 | 遺伝子操作した成長因子変異体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019211946A Division JP2020039359A (ja) | 2011-05-09 | 2019-11-25 | 遺伝子操作した成長因子変異体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017061471A JP2017061471A (ja) | 2017-03-30 |
| JP2017061471A5 true JP2017061471A5 (https=) | 2017-10-12 |
| JP6717725B2 JP6717725B2 (ja) | 2020-07-01 |
Family
ID=47139949
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014510413A Pending JP2014517690A (ja) | 2011-05-09 | 2012-05-08 | 遺伝子操作した成長因子変異体 |
| JP2016204089A Active JP6717725B2 (ja) | 2011-05-09 | 2016-10-18 | 遺伝子操作した成長因子変異体 |
| JP2019211946A Pending JP2020039359A (ja) | 2011-05-09 | 2019-11-25 | 遺伝子操作した成長因子変異体 |
| JP2021193554A Pending JP2022031824A (ja) | 2011-05-09 | 2021-11-29 | 遺伝子操作した成長因子変異体 |
| JP2024006988A Pending JP2024056702A (ja) | 2011-05-09 | 2024-01-19 | 遺伝子操作した成長因子変異体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014510413A Pending JP2014517690A (ja) | 2011-05-09 | 2012-05-08 | 遺伝子操作した成長因子変異体 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019211946A Pending JP2020039359A (ja) | 2011-05-09 | 2019-11-25 | 遺伝子操作した成長因子変異体 |
| JP2021193554A Pending JP2022031824A (ja) | 2011-05-09 | 2021-11-29 | 遺伝子操作した成長因子変異体 |
| JP2024006988A Pending JP2024056702A (ja) | 2011-05-09 | 2024-01-19 | 遺伝子操作した成長因子変異体 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20140065113A1 (https=) |
| EP (1) | EP2707021B1 (https=) |
| JP (5) | JP2014517690A (https=) |
| CN (2) | CN103930439A (https=) |
| AU (1) | AU2012253652B2 (https=) |
| CA (1) | CA2835453A1 (https=) |
| IL (1) | IL229316B (https=) |
| WO (1) | WO2012154759A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2686418A4 (en) | 2011-03-17 | 2015-04-22 | Minerva Biotechnologies Corp | METHOD FOR THE PRODUCTION OF PLURIPOTENTAL STEM CELLS |
| WO2012154759A2 (en) * | 2011-05-09 | 2012-11-15 | Minerva Biotechnologies Corporation | Genetically engineered growth factor variants |
| CA2901893C (en) * | 2013-02-20 | 2022-08-30 | Minerva Biotechnologies Corporation | Nme inhibitors and methods of using nme inhibitors |
| AU2015332389A1 (en) * | 2014-10-16 | 2017-04-20 | Myriad Women's Health, Inc. | Variant caller |
| CA3183682A1 (en) | 2020-06-26 | 2021-12-30 | Minerva Biotechnologies Corporation | Anti-nme antibody and method of treating cancer or cancer metastasis |
| US12144827B2 (en) | 2021-02-25 | 2024-11-19 | Lyell Immunopharma, Inc. | ROR1 targeting chimeric antigen receptor |
| CN119317447A (zh) | 2022-04-12 | 2025-01-14 | 米纳瓦生物技术公司 | 抗可变muc1*抗体及其用途 |
| CN117736272B (zh) * | 2024-02-19 | 2024-04-30 | 四川省医学科学院·四川省人民医院 | 一种具有促成骨功能的生物活性多肽 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69033810T2 (de) * | 1989-10-18 | 2002-03-28 | The Government Of The United States Of America, As Represented By The Secretary National Institute Of Health | Herstellung und verwendung des menschlichen nm23-h2-proteins und dagegen gerichtete antikörper |
| US5958671A (en) * | 1996-04-23 | 1999-09-28 | Presidents And Fellows Of Harvard College | Methods and compositions for regulating T cell subsets by modulating transcription factor activity |
| US20050112607A1 (en) * | 1999-01-23 | 2005-05-26 | Bamdad Cynthia C. | Rapid and sensitive detection of protein aggregation |
| US7550143B2 (en) * | 2005-04-06 | 2009-06-23 | Ibc Pharmaceuticals, Inc. | Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
| US7754855B1 (en) * | 1999-07-13 | 2010-07-13 | Bolder Biotechnology, Inc. | Immunoglobulin fusion proteins |
| MXPA02001417A (es) * | 1999-08-09 | 2002-08-12 | Lexigen Pharm Corp | Complejos multiples de citosina-anticuerpo. |
| US20020169290A1 (en) * | 2000-11-02 | 2002-11-14 | Claus Bornaes | New multimeric interferon beta polypeptides |
| WO2002036626A1 (en) * | 2000-11-02 | 2002-05-10 | Maxygen Aps | Single-chain multimeric polypeptides |
| US7829084B2 (en) * | 2001-01-17 | 2010-11-09 | Trubion Pharmaceuticals, Inc. | Binding constructs and methods for use thereof |
| EP1397484A4 (en) * | 2001-03-27 | 2005-05-25 | Massachusetts Inst Technology | METHODS AND PRODUCTS ASSOCIATED WITH FGF DIMERIZATION |
| EP1353182A3 (en) * | 2002-04-12 | 2004-02-04 | Smithkline Beecham Corporation | Method of predicting cell-based assay results using binding profiles |
| AU2003268345A1 (en) * | 2002-09-24 | 2004-04-19 | The Burnham Institute | Novel agents that modulate eph receptor activity |
| NZ544924A (en) * | 2003-06-27 | 2009-03-31 | Biogen Idec Inc | Modified binding molecules comprising connecting peptides |
| US20050054752A1 (en) * | 2003-09-08 | 2005-03-10 | O'brien John P. | Peptide-based diblock and triblock dispersants and diblock polymers |
| BRPI0507174A (pt) * | 2004-01-28 | 2008-04-01 | Syntonix Pharmaceuticals Inc | proteìnas de fusão hormÈnio-fc (fsh-fc) heterodiméricas estimuladoras de folìculo para o tratamento da infertilidade |
| NZ573646A (en) * | 2006-06-12 | 2012-04-27 | Wyeth Llc | Single-chain multivalent binding proteins with effector function |
| US20090075926A1 (en) * | 2006-12-06 | 2009-03-19 | Bamdad Cynthia C | Method for identifying and manipulating cells |
| NZ590667A (en) * | 2008-07-02 | 2013-01-25 | Emergent Product Dev Seattle | Tgf-b antagonist multi-target binding proteins |
| CN102272290B (zh) * | 2008-10-09 | 2018-08-14 | 米纳瓦生物技术公司 | 用于在细胞中诱导多能性的方法 |
| MX2011013385A (es) * | 2009-06-11 | 2012-05-29 | Minerva Biotechnologies Corp | Metodos para cultivar celulas madre y celulas progenitoras. |
| WO2011103049A2 (en) * | 2010-02-16 | 2011-08-25 | Immune Disease Institute, Inc. | Method for screening receptors/ligands interactions |
| EP2686418A4 (en) * | 2011-03-17 | 2015-04-22 | Minerva Biotechnologies Corp | METHOD FOR THE PRODUCTION OF PLURIPOTENTAL STEM CELLS |
| WO2012154759A2 (en) * | 2011-05-09 | 2012-11-15 | Minerva Biotechnologies Corporation | Genetically engineered growth factor variants |
-
2012
- 2012-05-08 WO PCT/US2012/036975 patent/WO2012154759A2/en not_active Ceased
- 2012-05-08 AU AU2012253652A patent/AU2012253652B2/en active Active
- 2012-05-08 CN CN201280034119.XA patent/CN103930439A/zh active Pending
- 2012-05-08 CA CA2835453A patent/CA2835453A1/en active Pending
- 2012-05-08 JP JP2014510413A patent/JP2014517690A/ja active Pending
- 2012-05-08 CN CN202010915430.1A patent/CN112028985A/zh active Pending
- 2012-05-08 EP EP12782984.4A patent/EP2707021B1/en active Active
-
2013
- 2013-11-07 IL IL229316A patent/IL229316B/en active IP Right Grant
- 2013-11-11 US US14/077,061 patent/US20140065113A1/en not_active Abandoned
-
2016
- 2016-10-18 JP JP2016204089A patent/JP6717725B2/ja active Active
-
2019
- 2019-06-20 US US16/447,812 patent/US20200062812A1/en not_active Abandoned
- 2019-11-25 JP JP2019211946A patent/JP2020039359A/ja active Pending
-
2021
- 2021-11-29 JP JP2021193554A patent/JP2022031824A/ja active Pending
-
2024
- 2024-01-19 JP JP2024006988A patent/JP2024056702A/ja active Pending
- 2024-04-19 US US18/640,690 patent/US20240294590A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017061471A5 (https=) | ||
| TWI856979B (zh) | 三特異性抗ｃｄ３８、抗ｃｄ２８和抗ｃｄ３結合蛋白和用於治療病毒感染的使用方法 | |
| JP7227290B2 (ja) | キメラ抗原受容体、組成物及び方法 | |
| US20240279303A1 (en) | Tissue-specific wnt signal enhancing molecules and uses thereof | |
| TWI860971B (zh) | 用於結合ａｘｌ之嵌合抗原受體、經分離之重組ｔ細胞、載體及在體外活化ｔ細胞的方法 | |
| JP2014517690A5 (https=) | ||
| JP2024105296A (ja) | Ｍａｇｅ－ａに特異的に結合する抗原結合タンパク質 | |
| CN104968361B (zh) | 用于治疗或预防疾病的因子1蛋白、因子2蛋白及其抑制剂 | |
| JP2018512856A5 (https=) | ||
| JP2018519296A5 (https=) | ||
| JP2020510658A (ja) | 操作されたヘテロ二量体タンパク質 | |
| CN107406509A (zh) | 包含结合至5t4和cd3的三个结合结构域的融合蛋白 | |
| CN107223135A (zh) | 用于治疗hbv感染和相关病症的三特异性结合分子 | |
| JP2014519830A5 (https=) | ||
| JP2016516049A5 (https=) | ||
| CN101360758A (zh) | 用于登革病毒的4种血清型和其他黄病毒的预防和/或治疗性治疗的方法和蛋白质 | |
| US20220218752A1 (en) | Lockr-mediated recruitment of car t cells | |
| CN105658235A (zh) | 能够结合gpA33和CD3的双特异性单价双抗体及其用途 | |
| CN107709355A (zh) | 单链cd40受体激动剂蛋白 | |
| Zhang et al. | Functional antibody CDR3 fusion proteins with enhanced pharmacological properties | |
| JP6717725B2 (ja) | 遺伝子操作した成長因子変異体 | |
| JP2018538356A5 (https=) | ||
| JP2018530331A5 (https=) | ||
| JP2014510519A5 (https=) | ||
| JP2025137512A (ja) | 新規に設計された共局在化依存性タンパク質スイッチを使用する超特異的細胞標的化 |